Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1998-5-4
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0887-6924
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
635-6
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9557626-Complement Activation,
pubmed-meshheading:9557626-Complement C3,
pubmed-meshheading:9557626-Complement C4,
pubmed-meshheading:9557626-Humans,
pubmed-meshheading:9557626-Immunohistochemistry,
pubmed-meshheading:9557626-Leukemia, Lymphocytic, Chronic, B-Cell,
pubmed-meshheading:9557626-Prognosis
|
pubmed:year |
1998
|
pubmed:articleTitle |
Complement values in B chronic lymphocytic leukemia: prognostic significance and correlation with cell maturation stage.
|
pubmed:publicationType |
Letter,
Comment
|